147 related articles for article (PubMed ID: 33181335)
1. Designing of a novel multi-epitope peptide based vaccine against Brugia malayi: An in silico approach.
Das NC; Patra R; Gupta PSS; Ghosh P; Bhattacharya M; Rana MK; Mukherjee S
Infect Genet Evol; 2021 Jan; 87():104633. PubMed ID: 33181335
[TBL] [Abstract][Full Text] [Related]
2. Immune targeting of filarial glutaredoxin through a multi-epitope peptide-based vaccine: A reverse vaccinology approach.
Das NC; Gorai S; Gupta PSS; Panda SK; Rana MK; Mukherjee S
Int Immunopharmacol; 2024 May; 133():112120. PubMed ID: 38657497
[TBL] [Abstract][Full Text] [Related]
3. Identification of a highly immunoreactive epitope of Brugia malayi TPx recognized by the endemic sera.
Madhumathi J; Prince PR; Gayatri SC; Aparnaa R; Kaliraj P
J Parasitol; 2010 Dec; 96(6):1228-9. PubMed ID: 21158641
[TBL] [Abstract][Full Text] [Related]
4. Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.
Immanuel C; Ramanathan A; Balasubramaniyan M; Khatri VK; Amdare NP; Rao DN; Reddy MVR; Perumal K
Immunol Res; 2017 Jun; 65(3):729-738. PubMed ID: 28432603
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a multi-epitope in silico vaccine model for lymphatic filariasis by targeting
Madanagopal P; Muthusamy S; Pradhan SN; Prince PR
Bull Natl Res Cent; 2023; 47(1):47. PubMed ID: 36987521
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis.
Madhumathi J; Prince PR; Anugraha G; Kiran P; Rao DN; Reddy MV; Kaliraj P
Vaccine; 2010 Jul; 28(31):5038-48. PubMed ID: 20653106
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.
Veerapathran A; Dakshinamoorthy G; Gnanasekar M; Reddy MV; Kalyanasundaram R
PLoS Negl Trop Dis; 2009 Jun; 3(6):e457. PubMed ID: 19513102
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Brugia malayi antigenic peptides: candidates for synthetic vaccine design against lymphatic filariasis.
Gomase VS; Chitlange NR; Changbhale SS; Kale KV
Protein Pept Lett; 2013 Aug; 20(8):864-87. PubMed ID: 23537185
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.
Verma SK; Bansal I; Vedi S; Saxena JK; Katoch VM; Bhattacharya SM
Parasitol Res; 2008 Feb; 102(3):481-9. PubMed ID: 18064491
[TBL] [Abstract][Full Text] [Related]
10. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.
Gregory WF; Atmadja AK; Allen JE; Maizels RM
Infect Immun; 2000 Jul; 68(7):4174-9. PubMed ID: 10858234
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis.
Madhumathi J; Prince PR; Rao DN; Karande AA; Reddy MV; Kaliraj P
J Helminthol; 2017 Jan; 91(1):43-54. PubMed ID: 26892175
[TBL] [Abstract][Full Text] [Related]
12. Proliferative responses of Brugia malayi TPX-1 and its epitopic peptide(29-43) in an endemic population of human lymphatic filariasis.
Madhumathi J; Anugraha G; Prince PR; Pradiba D; Kaliraj P
Microbes Infect; 2011 Jun; 13(6):602-6. PubMed ID: 21288496
[TBL] [Abstract][Full Text] [Related]
13. Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates.
Khatri V; Chauhan N; Vishnoi K; von Gegerfelt A; Gittens C; Kalyanasundaram R
Int J Parasitol; 2018 Aug; 48(9-10):773-783. PubMed ID: 29885437
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Vanam U; Pandey V; Prabhu PR; Dakshinamurthy G; Reddy MV; Kaliraj P
Am J Trop Med Hyg; 2009 Feb; 80(2):319-24. PubMed ID: 19190232
[TBL] [Abstract][Full Text] [Related]
15. Designing efficient multi-epitope peptide-based vaccine by targeting the antioxidant thioredoxin of bancroftian filarial parasite.
Gorai S; Das NC; Gupta PSS; Panda SK; Rana MK; Mukherjee S
Infect Genet Evol; 2022 Mar; 98():105237. PubMed ID: 35131521
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of a cloned Brugia malayi antigen in a mouse model of microfilaremia.
Kazura JW; Maroney PA; Pearlman E; Nilsen TW
J Immunol; 1990 Oct; 145(7):2260-4. PubMed ID: 2398279
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase.
Arya H; Coumar MS
J Mol Model; 2014 Jun; 20(6):2266. PubMed ID: 24842326
[TBL] [Abstract][Full Text] [Related]
18. Humans from Wuchereria bancrofti endemic area elicit substantial immune response to proteins of the filarial parasite Brugia malayi and its endosymbiont Wolbachia.
Jha R; Gangwar M; Chahar D; Setty Balakrishnan A; Negi MP; Misra-Bhattacharya S
Parasit Vectors; 2017 Jan; 10(1):40. PubMed ID: 28118850
[TBL] [Abstract][Full Text] [Related]
19. Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.
Kushwaha V; Tewari P; Mandal P; Tripathi A; Murthy PK
Parasitol Res; 2019 Jun; 118(6):1849-1863. PubMed ID: 31055672
[TBL] [Abstract][Full Text] [Related]
20. Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: An immunoinformatics approach.
Das NC; Gupta PSS; Panda SK; Rana MK; Mukherjee S
Int Immunopharmacol; 2023 Feb; 115():109639. PubMed ID: 36586276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
